Characterization of M2 muscarinic receptor activation of different G protein subtypes

Neurochemistry International

Volumn 44, Issue 2, 2004, Pages 119-124

  Uustare, Ain ^a   Näsman, Johnny ^b   Åkerman, Karl E O ^b   Rinken, Ago ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

G proteins; Muscarinic receptors; Sf9 cells; Subtype selectivity; 35S GTP S binding assay

Indexed keywords

ATROPINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); METHYLSCOPOLAMINE; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PROTEIN SUBUNIT; SCOPOLAMINE;

ANIMAL CELL; ARTICLE; BACULOVIRUS; BINDING AFFINITY; INSECT CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION;

INSECTA; SPODOPTERA; SPODOPTERA FRUGIPERDA; UNIDENTIFIED BACULOVIRUS;

EID: 0042326250     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(03)00103-7     Document Type: Article

References (26)

1. Butkerait P., Zheng J., Hallak H., Graham T.E., Miller H.A., Burris K.D., Molinoff P.B., Manning D.R. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J. Biol. Chem. 270:1995;18691-18699.
2. Caulfield M.P., Birdsall N.J. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50:1998;279-290.
3. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
4. 4-muscarinic acetylcholine receptors to calmodulin-sensitive adenylyl cyclases - crossover from G protein-coupled inhibition to stimulation. Biochemistry. 33:1994;943-951.
5. 5) expressed in baculovirus-infected insect cells. J. Pharmacol. Exp. Ther. 274:1995;378-384.
6. Ford D.J., Essex A., Spalding T.A., Burstein E.S., Ellis J. Homologous mutations near the junction of the sixth transmembrane domain and the third extracellular loop lead to constitutive activity and enhanced agonist affinity at all muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 300:2002;810-817.
7. Haga T., Ikegaya T., Haga K. The interaction of acetylcholine receptors in porcine atrial membranes with three kinds of G proteins. Jpn. Circ. J. 54:1990;1176-1184.
8. Järv, J., Rinken, A., 1993. Muscarinic acetylcholine receptors. In: Hucho, F. (Ed.) Neurotransmitter Receptors. Elsevier, Amsterdam, pp. 199-220.
9. oA differentially determine kinetic efficacies of agonists for κ-opioid receptor. FEBS Lett. 473:2000;101-105.
10. Leopoldt D., Harteneck C., Nurnberg B. G proteins endogenously expressed in Sf9 cells: interactions with mammalian histamine receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 356:1997;216-224.
11. 1-like receptors expressed in Sf9 cells. Eur. J. Pharmacol. 420:2001;73-82.
12. 2 acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists. Br. J. Pharmacol. 132:2001;1217-1228.
13. 1 muscarinic receptors. Biochem. Biophys. Res. Commun. 271:2000;435-439.
14. 2-adrenoceptors. Biochem. Pharmacol. 62:2001;913-922.
15. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 80:1995;249-257.
16. 2short receptor by partial agonists in a G-protein-dependent manner. Biochem. Pharmacol. 62:2001;723-732.
17. Peterson G.L. Determination of total protein. Methods Enzymol. 91:1983;95-119.
18. 3 dopamine receptor Neurosci. Lett. 226:1997;91-94.
19. Rinken A. Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected Sf9 insect cell membranes. J. Pharmacol. Exp. Ther. 272:1995;8-14.
20. Rinken A., Kameyama K., Haga T., Engström L. Solubilization of muscarinic receptor subtypes from baculovirus infected Sf9 insect cells. Biochem. Pharmacol. 48:1994;1245-1251.
21. 35S ]GTPγS binding in rat striatal membranes Biochem. Pharmacol. 57:1999;155-162.
22. Sunahara R.K., Dessauer C.W., Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36:1996;461-480.
23. o proteins. Cell Res. 10:2000;93-102.
24. q-proteins. Mol. Pharmacol. 58:2000;954-966.
25. Windh R.T., Manning D.R. Expression of G protein-coupled receptors and G proteins in Sf9 cells: analysis of coupling by radioligand binding. Methods Enzymol. 343:2002;417-429.
26. Yang Q., Lanier S.M. Influence of G protein type on agonist efficacy. Mol. Pharmacol. 56:1999;651-656.